Literature DB >> 20419844

LOH analysis of genes around D4S2964 identifies ARD1B as a prognostic predictor of hepatocellular carcinoma.

Guo-Liang Huang1, Bin-Kui Li, Mei-Yin Zhang, Hui-Zhong Zhang, Rong-Rong Wei, Yun-Fei Yuan, Ming Shi, Xiao-Qian Chen, Long Huang, An-Hua Li, Bi-Jun Huang, Hong-Hua Li, Hui-Yun Wang.   

Abstract

AIM: To investigate genes around the locus D4S2964 affected by loss of heterozygosity (LOH) and their clinical implications.
METHODS: Four hundred and forty single nucleotide polymorphisms (SNPs) located at 49 genes around D4S2964 were selected from the National Center for Biotechnology Information website for the SNPs microarray fabrication. LOH of SNPs markers in 112 cases of hepatocellular carcinoma (HCC) tissues and paired adjacent liver tissues were investigated by the SNPs microarray. The correlation between allelic losses with clinicopathological features and overall survival was analyzed.
RESULTS: A fine map of LOH of SNPs in genes around D4S2964 was plotted. The average frequency of LOH in genes was 0.39. A correlation between cirrhosis and the FAL index (fractional allelic loss) was found (P = 0.0202). Larger tumor size was found to be significantly associated with LOH in genes ADP-ribosyltransferase 3 (ART3), nucleoporin 54 kDa (NUP54), scavenger receptor class B, member 2 (SCARB2) and coiled-coil domain containing 158 (CCDC158) (P = 0.043, P = 0.019, P = 0.001, P = 0.037, respectively). Kaplan-Meier analysis showed that patients with LOH in ARD1 homolog B (ARD1B) and septin 11 (SEPT11) had a significantly lower survival rate than those with retention (P = 0.021 and P = 0.004, respectively). A Cox regression model suggested that LOH in ARD1B and SEPT11, respectively, were predictors of the overall survival in HCC (P = 0.006 and P = 0.026, respectively).
CONCLUSION: LOH in genes around D4S2964 may play an important role in HCC development and progression. LOH in ARD1B and SEPT11 could serve as novel prognostic predictors in HCC patients.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20419844      PMCID: PMC2860084          DOI: 10.3748/wjg.v16.i16.2046

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  36 in total

1.  A genotyping system capable of simultaneously analyzing >1000 single nucleotide polymorphisms in a haploid genome.

Authors:  Hui-Yun Wang; Minjie Luo; Irina V Tereshchenko; Danielle M Frikker; Xiangfeng Cui; James Y Li; Guohong Hu; Yi Chu; Marco A Azaro; Yong Lin; Li Shen; Qifeng Yang; Manousos E Kambouris; Richeng Gao; Weichung Shih; Honghua Li
Journal:  Genome Res       Date:  2005-02       Impact factor: 9.043

2.  Genome-wide semiquantitative microsatellite analysis of human hepatocellular carcinoma: discrete mapping of smallest region of overlap of recurrent chromosomal gains and losses.

Authors:  Takafumi Nishimura; Naoshi Nishida; Toshiki Komeda; Yoshihiro Fukuda; Iwao Ikai; Yoshio Yamaoka; Kazuwa Nakao
Journal:  Cancer Genet Cytogenet       Date:  2006-05

3.  Frequent allelic loss on chromosomes 4q and 16q associated with human hepatocellular carcinoma in Taiwan.

Authors:  Y H Chou; K C Chung; L B Jeng; T C Chen; Y F Liaw
Journal:  Cancer Lett       Date:  1998-01-16       Impact factor: 8.679

4.  Deletion mapping of chromosome 4 in head and neck squamous cell carcinoma.

Authors:  M A Pershouse; A K El-Naggar; K Hurr; H Lin; W K Yung; P A Steck
Journal:  Oncogene       Date:  1997-01-23       Impact factor: 9.867

5.  Major causes of death among men and women in China.

Authors:  Jiang He; Dongfeng Gu; Xigui Wu; Kristi Reynolds; Xiufang Duan; Chonghua Yao; Jialiang Wang; Chung-Shiuan Chen; Jing Chen; Rachel P Wildman; Michael J Klag; Paul K Whelton
Journal:  N Engl J Med       Date:  2005-09-15       Impact factor: 91.245

6.  Mapping of genetic deletions on the long arm of chromosome 4 in human esophageal adenocarcinomas.

Authors:  C A Rumpel; S M Powell; C A Moskaluk
Journal:  Am J Pathol       Date:  1999-05       Impact factor: 4.307

7.  Clinicopathological significance of loss of heterozygosity and microsatellite instability in hepatocellular carcinoma in China.

Authors:  Shu-Hui Zhang; Wen-Ming Cong; Zhi-Hong Xian; Meng-Chao Wu
Journal:  World J Gastroenterol       Date:  2005-05-28       Impact factor: 5.742

8.  Frequent microsatellite alterations of chromosome locus 4q13.1 in oral squamous cell carcinomas.

Authors:  Shu-Chun Lin; Mei-Fong Chang; Ming-Yi Chung; Che-Shoa Chang; Shou-Yen Kao; Chung-Ji Liu; Kuo-Wei Chang
Journal:  J Oral Pathol Med       Date:  2005-04       Impact factor: 4.253

9.  Deletion mapping of chromosome 4q in hepatocellular carcinoma.

Authors:  Z Piao; C Park; J H Park; H Kim
Journal:  Int J Cancer       Date:  1998-08-21       Impact factor: 7.396

10.  Genetic alterations in hepatocellular carcinomas: association between loss of chromosome 4q and p53 gene mutations.

Authors:  A Rashid; J S Wang; G S Qian; B X Lu; S R Hamilton; J D Groopman
Journal:  Br J Cancer       Date:  1999-04       Impact factor: 7.640

View more
  6 in total

1.  Polymorphisms in the 3'-UTR of SCD5 gene are associated with hepatocellular carcinoma in Korean population.

Authors:  Gyeong Im Yu; Kwang Ho Mun; Seon Hee Yang; Dong Hoon Shin; Jae Seok Hwang
Journal:  Mol Biol Rep       Date:  2018-08-30       Impact factor: 2.316

2.  Expression of human NAA11 (ARD1B) gene is tissue-specific and is regulated by DNA methylation.

Authors:  Alan L Y Pang; Jessica Clark; Wai-Yee Chan; Owen M Rennert
Journal:  Epigenetics       Date:  2011-11-01       Impact factor: 4.528

Review 3.  Genetic alterations in hepatocellular carcinoma: An update.

Authors:  Zhao-Shan Niu; Xiao-Jun Niu; Wen-Hong Wang
Journal:  World J Gastroenterol       Date:  2016-11-07       Impact factor: 5.742

Review 4.  ARD1/NAA10 in hepatocellular carcinoma: pathways and clinical implications.

Authors:  Danbi Lee; Myoung-Kuk Jang; Ji Hae Seo; Soo Hyung Ryu; Jeong A Kim; Young-Hwa Chung
Journal:  Exp Mol Med       Date:  2018-07-27       Impact factor: 8.718

5.  Allele loss and down-regulation of heparanase gene are associated with the progression and poor prognosis of hepatocellular carcinoma.

Authors:  Guo-Liang Huang; Bin-Kui Li; Mei-Yin Zhang; Rong-Rong Wei; Yun-Fei Yuan; Ming Shi; Xiao-Qian Chen; Long Huang; Hui-Zhong Zhang; Wanqing Liu; Bi-Jun Huang; Honghua Li; Xiao-Feng Zheng; Xian-Rong Luo; Hui-Yun Wang
Journal:  PLoS One       Date:  2012-08-31       Impact factor: 3.240

6.  ART3 regulates triple-negative breast cancer cell function via activation of Akt and ERK pathways.

Authors:  Ling Tan; Xiaodan Song; Xin Sun; Ning Wang; Ying Qu; Zhijun Sun
Journal:  Oncotarget       Date:  2016-07-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.